Cixutumumab
Jump to navigation
Jump to search
| Cixutumumab | |
|---|---|
| Term | Cixutumumab |
| Short definition | Cixutumumab - (pronounced) (SIK-syoo-TOO-myoo-mab) A substance being studied to treat some types of cancer. It is a monoclonal antibody made in the laboratory that can bind to substances in the body. |
| Type | Cancer terms |
| Specialty | Oncology |
| Language | English |
| Source | NCI |
| Comments | |
Cixutumumab - (pronounced) (SIK-syoo-TOO-myoo-mab) A substance being studied to treat some types of cancer. It is a monoclonal antibody made in the laboratory that can bind to substances in the body. Cixutumumab blocks the action of a protein needed for cell growth and can kill cancer cells. It is a type of insulin-like growth factor 1 receptor (IGF-1R) inhibitor. Also called IMC-A12
External links
- Medical encyclopedia article on Cixutumumab
- Wikipedia's article - Cixutumumab
This WikiMD dictionary article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski